These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24641588)

  • 1. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.
    Ortega VE
    Clin Genet; 2014 Jul; 86(1):12-20. PubMed ID: 24641588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma pharmacogenetics: responding to the call for a personalized approach.
    Ortega VE; Wechsler ME
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):399-409. PubMed ID: 23799335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.
    Ortega VE; Meyers DA
    J Allergy Clin Immunol; 2014 Jan; 133(1):16-26. PubMed ID: 24369795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
    Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of beta2-agonist: key focus on signaling pathways.
    Bhatnagar P; Guleria R; Kukreti R
    Pharmacogenomics; 2006 Sep; 7(6):919-33. PubMed ID: 16981850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of β2-agonists.
    Hizawa N
    Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
    Chung LP; Waterer G; Thompson PJ
    Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic tests in asthma therapy.
    Yu IW; Bukaveckas BL
    Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of the beta 2-adrenergic receptor gene.
    Ortega VE; Hawkins GA; Peters SP; Bleecker ER
    Immunol Allergy Clin North Am; 2007 Nov; 27(4):665-84; vii. PubMed ID: 17996583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of long-acting β2-agonists.
    Blake K; Lima J
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1733-51. PubMed ID: 26235677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy.
    Kim SH; Ye YM; Lee HY; Sin HJ; Park HS
    J Clin Pharm Ther; 2011 Jun; 36(3):399-405. PubMed ID: 21545619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field.
    Contopoulos-Ioannidis DG; Kouri I; Ioannidis JP
    Pharmacogenomics; 2007 Aug; 8(8):933-58. PubMed ID: 17716228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and the development of personalized approaches for combination therapy in asthma.
    Miller SM; Ortega VE
    Curr Allergy Asthma Rep; 2013 Oct; 13(5):443-52. PubMed ID: 23912588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of polymorphisms of beta2 adrenoceptors on response to long-acting beta2 agonists in Iranian asthmatic patients.
    Soleimani F; Fahimi F; Adimi Naghan P; Nadji SA; Morowati S; Naderi N; Masjedi MR
    Iran J Allergy Asthma Immunol; 2013 Aug; 12(4):383-90. PubMed ID: 23996715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical consequences of ADRbeta2 polymorphisms.
    Hawkins GA; Weiss ST; Bleecker ER
    Pharmacogenomics; 2008 Mar; 9(3):349-58. PubMed ID: 18303970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of long-acting beta2-agonists in the treatment of asthma.
    Cazzola M; Matera MG
    Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
    Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L
    Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.